Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.
King DM, Albertini MR, Schalch H, Hank JA, Gan J, Surfus J, Mahvi D, Schiller JH, Warner T, Kim K, Eickhoff J, Kendra K, Reisfeld R, Gillies SD, Sondel P. King DM, et al. Among authors: schiller jh. J Clin Oncol. 2004 Nov 15;22(22):4463-73. doi: 10.1200/JCO.2004.11.035. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483010 Free PMC article. Clinical Trial.
A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancer.
Gambacorti-Passerini C, Hank JA, Albertini MR, Borchert AA, Moore KH, Schiller JH, Bechhofer R, Borden EC, Storer B, Sondel PM. Gambacorti-Passerini C, et al. Among authors: schiller jh. J Immunother Emphasis Tumor Immunol. 1993 Jan;13(1):43-8. doi: 10.1097/00002371-199301000-00006. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8435431 Clinical Trial.
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors.
Surfus JE, Hank JA, Oosterwijk E, Welt S, Lindstrom MJ, Albertini MR, Schiller JH, Sondel PM. Surfus JE, et al. Among authors: schiller jh. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):184-91. doi: 10.1097/00002371-199605000-00003. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8811493
264 results